NCT02081066View on ClinicalTrials.gov

Identification of CETP as a Marker of Atherosclerosis

NACompletedINTERVENTIONAL
Enrollment

99

Participants

Timeline

Start Date

September 25, 2014

Primary Completion Date

September 30, 2020

Study Completion Date

September 30, 2020

Conditions
Cardiovascular Disease
Interventions
OTHER

cardiovascular risk factors

Trial Locations (1)

75013

Inserm Umrs1166, Paris

All Listed Sponsors
lead

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

NCT02081066 - Identification of CETP as a Marker of Atherosclerosis | Biotech Hunter | Biotech Hunter